• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MAGE-A11 表达有助于头颈部癌症的顺铂耐药性。

MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer.

机构信息

Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, Pleicherwall 2, 97070, Würzburg, Germany.

Interdisciplinary Center for Clinical Research, University Hospital Würzburg, Josef-Schneider-Straße 2, 97070, Würzburg, Germany.

出版信息

Clin Oral Investig. 2018 Apr;22(3):1477-1486. doi: 10.1007/s00784-017-2242-8. Epub 2017 Oct 15.

DOI:10.1007/s00784-017-2242-8
PMID:29034444
Abstract

OBJECTIVE

The objective of this study is to investigate the roles of melanoma-associated antigens (MAGEs) in the cisplatin treatment of head and neck cancer.

MATERIALS AND METHODS

We assessed the efficacy of cisplatin in a set of four head and neck cancer cell lines using a crystal violet assay. The MAGE-A expression in all cell lines was measured with RT-qPCR. The correlation between MAGE-A expression and cisplatin efficacy was investigated using Spearman's correlation analysis. Furthermore, we established a cell line with stable overexpression of MAGE-A11 and determined influence on proliferation, cisplatin efficacy and cell apoptosis. In this cell line, the effects of cisplatin were assessed using either crystal violet assays or flow cytometry (Annexin V).

RESULTS

For MAGE-A11, we observed the highest correlation (r = 1.000, p = 0.0417) with low cisplatin efficacy. Stable overexpression of MAGE-A11 resulted in no changes in proliferation, but in lower cisplatin cytotoxicity and lower rates of apoptosis. Also, mouse double minute 2 homolog (MDM2) expression was induced by MAGE-A11 overexpression.

CONCLUSION

We provide evidence that MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer.

CLINICAL RELEVANCE

Our study underscores the negative predictive role of MAGE-A11 expression in head and neck cancer.

摘要

目的

本研究旨在探讨黑色素瘤相关抗原(MAGEs)在顺铂治疗头颈部癌症中的作用。

材料与方法

我们使用结晶紫测定法评估了顺铂在四组头颈部癌细胞系中的疗效。使用 RT-qPCR 测量所有细胞系中的 MAGE-A 表达。使用 Spearman 相关分析研究 MAGE-A 表达与顺铂疗效之间的相关性。此外,我们建立了 MAGE-A11 稳定过表达的细胞系,并确定其对增殖、顺铂疗效和细胞凋亡的影响。在该细胞系中,使用结晶紫测定法或流式细胞术(Annexin V)评估顺铂的作用。

结果

对于 MAGE-A11,我们观察到与低顺铂疗效的相关性最高(r=1.000,p=0.0417)。MAGE-A11 的稳定过表达导致增殖无变化,但顺铂细胞毒性降低,细胞凋亡率降低。此外,MAGE-A11 过表达诱导了鼠双微体 2 同源物(MDM2)的表达。

结论

我们提供的证据表明,MAGE-A11 表达有助于头颈部癌症的顺铂耐药性。

临床相关性

我们的研究强调了 MAGE-A11 表达在头颈部癌症中具有负预测作用。

相似文献

1
MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer.MAGE-A11 表达有助于头颈部癌症的顺铂耐药性。
Clin Oral Investig. 2018 Apr;22(3):1477-1486. doi: 10.1007/s00784-017-2242-8. Epub 2017 Oct 15.
2
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.黑色素瘤相关抗原 A11 降低了头颈部癌症中厄洛替尼和阿法替尼的疗效。
J Craniomaxillofac Surg. 2018 Mar;46(3):492-497. doi: 10.1016/j.jcms.2017.12.014. Epub 2017 Dec 24.
3
Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells.MAGE-A肿瘤抗原与头颈部癌细胞中各种化疗药物疗效的相关性
Clin Oral Investig. 2014 Jan;18(1):189-97. doi: 10.1007/s00784-013-0936-0. Epub 2013 Feb 21.
4
Expression of MAGE-A11 in breast cancer tissues and its effects on the proliferation of breast cancer cells.MAGE-A11 在乳腺癌组织中的表达及其对乳腺癌细胞增殖的影响。
Mol Med Rep. 2013 Jan;7(1):254-8. doi: 10.3892/mmr.2012.1126. Epub 2012 Oct 12.
5
MAGE-A expression clusters and antineoplastic treatment in head and neck cancer.头颈部癌中的MAGE - A表达簇与抗肿瘤治疗
Int J Mol Med. 2015 Jun;35(6):1675-82. doi: 10.3892/ijmm.2015.2174. Epub 2015 Apr 7.
6
Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism.MAGE-A9 和 MAGE-A11 在乳腺癌中的表达及其表达机制。
Arch Med Res. 2014 Jan;45(1):44-51. doi: 10.1016/j.arcmed.2013.10.005. Epub 2013 Dec 5.
7
Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.黑色素瘤相关抗原(MAGE)-A3促进胃癌细胞增殖及化疗耐药。
Cell Oncol (Dordr). 2016 Apr;39(2):175-86. doi: 10.1007/s13402-015-0261-5. Epub 2016 Feb 11.
8
Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.卵巢癌中膜联蛋白A11的抑制:对化疗耐药性的影响。
Neoplasia. 2009 Jun;11(6):605-14, 1 p following 614. doi: 10.1593/neo.09286.
9
Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 Peptide.泽布勒林治疗通过一种新鉴定的HLA-A2限制性MAGE-A11肽诱导MAGE-A11表达并增强CTL细胞毒性。
J Immunother. 2017 Jul/Aug;40(6):211-220. doi: 10.1097/CJI.0000000000000170.
10
Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.人类p14-ARF肿瘤抑制因子对黑色素瘤抗原A11(MAGE-A11)的翻译后下调作用
J Biol Chem. 2015 Oct 9;290(41):25174-87. doi: 10.1074/jbc.M115.663641. Epub 2015 Sep 1.

引用本文的文献

1
MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer.MAGE-A11 是胃癌潜在的预后生物标志物和免疫治疗靶点。
Aging (Albany NY). 2024 Jan 4;16(1):285-298. doi: 10.18632/aging.205368.
2
MAGE-A10 Protein Expression in Advanced High Grade Serous Ovarian Cancer Is Associated with Resistance to First-Line Platinum-Based Chemotherapy.MAGE - A10蛋白在晚期高级别浆液性卵巢癌中的表达与一线铂类化疗耐药相关。
Cancers (Basel). 2023 Sep 23;15(19):4697. doi: 10.3390/cancers15194697.
3
TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.

本文引用的文献

1
Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 Peptide.泽布勒林治疗通过一种新鉴定的HLA-A2限制性MAGE-A11肽诱导MAGE-A11表达并增强CTL细胞毒性。
J Immunother. 2017 Jul/Aug;40(6):211-220. doi: 10.1097/CJI.0000000000000170.
2
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.黑色素瘤相关抗原(MAGE)在头颈部鳞状细胞癌原发肿瘤、淋巴结转移灶及各自复发灶中的表达——对免疫治疗的意义
Oncotarget. 2017 Feb 28;8(9):14719-14735. doi: 10.18632/oncotarget.14830.
3
TGM2、HMGA2、FXYD3 和 LGALS4 基因作为人结直肠癌细胞获得性奥沙利铂耐药的生物标志物:系统生物学方法。
PLoS One. 2023 Aug 3;18(8):e0289535. doi: 10.1371/journal.pone.0289535. eCollection 2023.
4
Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer.胃癌患者免疫相关分子亚型的特征及与免疫治疗反应相关的预后标志物。
Front Immunol. 2022 Jul 8;13:939836. doi: 10.3389/fimmu.2022.939836. eCollection 2022.
5
Emerging roles of the MAGE protein family in stress response pathways.MAGE 蛋白家族在应激反应途径中的新作用。
J Biol Chem. 2020 Nov 20;295(47):16121-16155. doi: 10.1074/jbc.REV120.008029. Epub 2020 Sep 13.
6
MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma.MAGE - A11表达可预测头颈部鳞状细胞癌患者的预后。
Cancer Manag Res. 2020 Feb 26;12:1427-1435. doi: 10.2147/CMAR.S237867. eCollection 2020.
7
Genetic variations in MAGE-A11 predict the risk and survival of renal cell cancer.MAGE - A11基因变异可预测肾细胞癌的风险和生存率。
J Cancer. 2019 Aug 27;10(20):4860-4865. doi: 10.7150/jca.32675. eCollection 2019.
8
MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.头颈部癌中的MAGE-A9:放疗背景下的预后价值及临床前研究结果
Mol Clin Oncol. 2018 Mar;8(3):513-519. doi: 10.3892/mco.2018.1558. Epub 2018 Jan 19.
Identification of MAGEA12 as a prognostic outlier gene in gastric cancers.
鉴定 MAGEA12 为胃癌的预后外显基因。
Neoplasma. 2017;64(2):238-243. doi: 10.4149/neo_2017_210.
4
The role of p53 in cancer drug resistance and targeted chemotherapy.p53在癌症耐药性和靶向化疗中的作用。
Oncotarget. 2017 Jan 31;8(5):8921-8946. doi: 10.18632/oncotarget.13475.
5
Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.食管鳞状细胞癌中癌胚基因高表达水平与临床特征的相关性
Histol Histopathol. 2017 Aug;32(8):793-803. doi: 10.14670/HH-11-847. Epub 2016 Nov 21.
6
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.纳武利尤单抗用于复发性头颈部鳞状细胞癌
N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8.
7
Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinoma.肿瘤前沿和中心黑色素瘤相关抗原-A表达情况相反:I期和IV期头颈部鳞状细胞癌的比较分析
Oncol Lett. 2016 Oct;12(4):2942-2947. doi: 10.3892/ol.2016.4945. Epub 2016 Aug 3.
8
Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray.基于 DNA 微阵列的 MAGE-A11 在食管鳞癌中的预后意义及相关基因的鉴定。
Arch Med Res. 2016 Apr;47(3):151-61. doi: 10.1016/j.arcmed.2016.06.001. Epub 2016 Jun 27.
9
Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma.MAGE-A1-A12亚组在口腔鳞状细胞癌侵袭性肿瘤前沿和肿瘤中心的表达
Oncol Rep. 2016 Apr;35(4):1979-86. doi: 10.3892/or.2016.4600. Epub 2016 Jan 28.
10
Prognostic value of MAGE-A9 expression in patients with colorectal cancer.MAGE-A9表达在结直肠癌患者中的预后价值。
Clin Res Hepatol Gastroenterol. 2016 Apr;40(2):239-45. doi: 10.1016/j.clinre.2015.08.005. Epub 2015 Oct 26.